Self-assembled "nanocubicle" as a carrier for peroral insulin delivery

Diabetologia
H ChungS Y Jeong

Abstract

A patient with (insulin-dependent) diabetes mellitus receives at least one subcutaneous insulin injection a day to maintain low serum glucose concentrations. Since patients' compliance with such dosage regimens is too low, the development of an oral formula is clearly attractive. We present the development of a liquid formula that can be easily dispersed in water to produce particles named "nanocubicles" which efficiently encapsulate insulin. Fasted streptozotocin-induced diabetic rats were administered orally with particles encapsulating insulin, and particles without insulin or soluble insulin in water. Groups of rats were also injected soluble insulin in PBS for control. Blood glucose concentration and insulin concentration were measured 1, 2, 3, 4 and 6 h after the administration of the insulin formulas. In vitro experiments show that the particles can be taken up by the Caco-2 cells at a high ratio. The serum glucose concentration was controlled for more than 6 h after oral insulin administration but returned to the basal concentration in 3 h when 1 IU/kg of insulin was injected intravenously. Our biocompatible and stable oral insulin formulation is easy to prepare and produces reproducible hypoglycaemic effects, therefore...Continue Reading

Citations

Oct 25, 2002·Diabetes/metabolism Research and Reviews
Sep 11, 2007·Pharmaceutical Research·Nitin K SwarnakarN K Jain
Feb 21, 2003·International Journal of Pharmaceutics·Jung Yoon UmSeo Young Jeong
Jul 5, 2003·International Journal of Pharmaceutics·Ben J Boyd
Jan 25, 2013·Therapeutic Delivery·Catarina Pinto ReisCatarina Rosado
Jul 25, 2012·Therapeutic Delivery·Thanigaivel Shanmugam, Rinti Banerjee
Jul 23, 2013·International Journal of Pharmaceutics·T T H PhamG Barratt
Nov 13, 2003·Drug Delivery·Jaleh VarshosazAbdolhossein Rouholamini Najafabadi
Feb 24, 2016·International Journal of Pharmaceutics·Nada MatouguiPatrick Saulnier
Jan 19, 2016·Drug Discovery Today·Zahra Karami, Mehrdad Hamidi
Jul 31, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Xingwang ZhangWei Wu
Mar 15, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Francesca ButtiniGaia Colombo
Nov 30, 2006·Diabetes & Metabolism·V Lassmann-Vague, D Raccah
Sep 23, 2008·Advances in Colloid and Interface Science·Anan Yaghmur, Otto Glatter
Aug 9, 2008·Journal of Colloid and Interface Science·Stefan SalentinigOtto Glatter
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kishore B ChalasaniSanjay K Jain
Aug 21, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kishore B ChalasaniSanjay K Jain
Nov 25, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·D R OwensG Bolli
Jul 13, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kathryn WhiteheadSamir Mitragotri
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Mohamed NasrAhmed Abdelazem
Sep 26, 2006·Drug Discovery Today·Mariko Morishita, Nicholas A Peppas
Sep 26, 2006·International Journal of Pharmaceutics·Abbas PardakhtyAbdolhossein Rouholamini
Apr 20, 2006·International Journal of Pharmaceutics·Ben J BoydGreg Davey
Apr 2, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Lukas BogeMartin Andersson
Aug 3, 2005·Progress in Biophysics and Molecular Biology·Sonika BhatnagarA K Dubey
Mar 9, 2005·Endocrinology and Metabolism Clinics of North America·Gabriel I Uwaifo, Robert E Ratner
Aug 15, 2012·Pharmaceutical Biology·Tin Wui WongAminah Kadir
Jun 17, 2004·AAPS PharmSci·Elisabetta EspositoRita Cortesi
Jun 23, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Abdul MuheemFarhan Jalees Ahmad
Oct 12, 2010·Drug Discovery Today·Chenyu GuoGuangxi Zhai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.